Synovus Financial Corp Biomarin Pharmaceutical Inc Transaction History

Synovus Financial Corp

$7.52 Billion
Q2 2024

A detailed history of Synovus Financial Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Synovus Financial Corp holds 24,062 shares of BMRN stock, worth $1.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

24,062

Previous 23,465 2.54%

Holding current value

$1.7 Million

Previous $2.05 Million 3.32%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $44,434 - $55,055	597 Added 2.54%	24,062 $1.98 Million
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $26,735 - $31,581	319 Added 1.38%	23,465 $2.05 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $423,053 - $469,849	4,973 Added 27.36%	23,146 $2.05 Million
Q2 2023 Aug 08, 2023	SELL	$86.68 - $100.3 $67,957 - $78,635	-784 Reduced 4.14%	18,173 $1.58 Million
Q1 2023 May 11, 2023	SELL	$87.74 - $117.27 $138,629 - $185,286	-1,580 Reduced 7.69%	18,957 $1.84 Million
Q4 2022 Feb 06, 2023	BUY	$80.93 - $108.63 $46,130 - $61,919	570 Added 2.85%	20,537 $2.13 Million
Q3 2022 Oct 27, 2022	SELL	$82.16 - $96.94 $8,216 - $9,694	-100 Reduced 0.5%	19,967 $1.69 Million
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $34,667 - $42,122	485 Added 2.48%	20,067 $1.66 Million
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $100,946 - $125,965	-1,359 Reduced 6.49%	19,582 $1.51 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $78,461 - $100,068	1,094 Added 5.51%	20,941 $1.85 Million
Q3 2021 Nov 08, 2021	BUY	$74.77 - $85.47 $102,883 - $117,606	1,376 Added 7.45%	19,847 $1.53 Million
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $40,322 - $45,277	534 Added 2.98%	18,471 $1.55 Million
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $2.34 Million - $2.84 Million	-31,308 Reduced 63.58%	17,937 $1.35 Million
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $31,367 - $38,966	432 Added 0.89%	49,245 $4.32 Million
Q3 2020 Nov 09, 2020	BUY	$71.87 - $131.03 $901,465 - $1.64 Million	12,543 Added 34.58%	48,813 $3.71 Million
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $664,719 - $1.04 Million	-8,356 Reduced 18.72%	36,270 $4.47 Million
Q1 2020 Apr 24, 2020	BUY	$71.37 - $96.85 $455,697 - $618,387	6,385 Added 16.7%	44,626 $3.78 Million
Q4 2019 Feb 06, 2020	BUY	$64.27 - $86.37 $132,781 - $178,440	2,066 Added 5.71%	38,241 $3.23 Million
Q3 2019 Nov 01, 2019	BUY	$67.4 - $85.11 $68,950 - $87,067	1,023 Added 2.91%	36,175 $2.44 Million
Q2 2019 Aug 08, 2019	BUY	$80.35 - $93.9 $264,431 - $309,024	3,291 Added 10.33%	35,152 $3.01 Million
Q1 2019 May 09, 2019	SELL	$84.2 - $98.62 $3,031 - $3,550	-36 Reduced 0.11%	31,861 $2.82 Million
Q4 2018 Feb 07, 2019	SELL	$80.14 - $106.07 $13,463 - $17,819	-168 Reduced 0.52%	31,897 $2.72 Million
Q3 2018 Nov 01, 2018	BUY	$93.92 - $105.72 $64,523 - $72,629	687 Added 2.19%	32,065 $3.11 Million
Q2 2018 Aug 01, 2018	SELL	$76.01 - $99.03 $66,356 - $86,453	-873 Reduced 2.71%	31,378 $2.95 Million
Q1 2018 May 07, 2018	BUY	$77.67 - $92.63 $296,544 - $353,661	3,818 Added 13.43%	32,251 $2.62 Million
Q4 2017 Feb 09, 2018	BUY	$80.76 - $95.13 $397,177 - $467,849	4,918 Added 20.91%	28,433 $2.54 Million
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $1.9 Million - $2.23 Million	23,515	23,515 $2.18 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Biomarin Pharmaceutical Inc Transaction History